| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |